Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0IE4H
|
|||
| Former ID |
DIB003557
|
|||
| Drug Name |
TAZOMELINE
|
|||
| Synonyms |
Hexylthio-TZTP; LY-287041; Tazomeline < Prop INN; NNC-11-0309; 3-[3-(Hexylthio)-1,2,5-thiadiazol-4-yl]-1-methyl-1,2,5,6-tetrahydropyridine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7] | Discontinued in Phase 1 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H23N3S2
|
|||
| Canonical SMILES |
CCCCCCSC1=NSN=C1C2=CCCN(C2)C
|
|||
| InChI |
1S/C14H23N3S2/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3
|
|||
| InChIKey |
XUHMGFKQBWZWPO-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 131987-54-7
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006554) | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.